AYTU BIOPHARMA, INC (AYTU) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $66.38M | +1.8% |
| 2024 | $65.18M | -39.3% |
| 2023 | $107.40M | +11.1% |
| 2022 | $96.67M | +47.3% |
| 2021 | $65.63M | +137.5% |
| 2020 | $27.63M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $66.38M | +1.8% |
| 2024 | $65.18M | -39.3% |
| 2023 | $107.40M | +11.1% |
| 2022 | $96.67M | +47.3% |
| 2021 | $65.63M | +137.5% |
| 2020 | $27.63M | — |